Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$19K Buy
416
+298
+253% +$13.7K 0.01% 1127
2026
Q2
$4K Sell
118
-190
-62% -$6.84K ﹤0.01% 1906
2026
Q1
$11K Sell
308
-47
-13% -$1.91K 0.01% 1341
2025
Q4
$14K Buy
355
+176
+98% +$7.66K 0.01% 1426
2025
Q3
$8K Sell
179
-4
-2% -$207 ﹤0.01% 1712
2025
Q2
$10K Sell
183
-124
-40% -$6.8K 0.01% 1584
2025
Q1
$18K Buy
307
+14
+5% +$902 0.01% 1228
2024
Q4
$20K Sell
293
-9
-3% -$627 0.01% 1184
2024
Q3
$22K Buy
302
+10
+3% +$706 0.01% 1172
2024
Q2
$21K Buy
292
+84
+40% +$6.13K 0.01% 1180
2024
Q1
$17K Buy
208
+136
+189% +$12.1K 0.01% 1268
2023
Q4
$8K Hold
72
– – 0.01% 1678
2023
Q3
$7K Hold
72
– – 0.01% 1608
2023
Q2
$10K Sell
72
-47
-39% -$5.74K 0.01% 1421
2023
Q1
$12K Sell
119
-83
-41% -$8.03K 0.01% 1213
2022
Q4
$18K Buy
202
+1
+0.5% +$83 0.01% 1063
2022
Q3
$16K Sell
201
-515
-72% -$48.6K 0.01% 1062
2022
Q2
$69K Buy
716
+710
+11,833% +$85.2K 0.05% 610
2022
Q1
$1K Sell
6
-2
-25% -$279 ﹤0.01% 1759
2021
Q4
$1K Buy
+8
New +$1.13K ﹤0.01% 1684

Other funds holding CNMD

Covestor's CNMD Position: Q3 2026 in Review

Covestor increased its CONMED (CNMD) stake by 253% in Q3 2026, buying an estimated $13.7K and bringing the position to 416 shares worth $19K. The position accounts for 0.01% of the portfolio, ranked #1127.

Covestor first reported a position in CNMD in Q4 2021 and has held it in 20 quarters since. The position peaked at $69K in Q2 2022. 270 funds tracked by Wall St. Rank hold CNMD as of Q3 2026.

  • Covestor held 416 shares of CONMED worth $19K as of Q3 2026.
  • Covestor bought 298 CONMED shares in Q3 2026, an estimated $13.7K.
  • CONMED made up 0.01% of Covestor's portfolio in Q3 2026, its #1127 holding.
  • Covestor first reported a position in CONMED in Q4 2021 and has held it in 20 quarters since.
  • Covestor's CONMED position peaked at $69K in Q2 2022.
  • 270 funds tracked by Wall St. Rank held CONMED as of Q3 2026.

Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.